ReviewTrends in pharmacological sciences2014

Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

Daniel J Hermanson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.